Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
412 Leser
Artikel bewerten:
(2)

US HealthCenter's PredictiMed Receives Another Validation from Validation Institute for it's Risk Burden Calculator

ROSEVILLE, CA / ACCESSWIRE / July 14, 2022 / Today on behalf of Validation Institute, US HealthCenter (USHC) and its PredictiMed AI Predictive Modeling Analytics Engine has been validated again and issued another stamp of approval.

US HealthCenter, Thursday, July 14, 2022, Press release picture

US HealthCenter is an AI based Software as a Service (SaaS) personalized, predictive medicine analytics and population health management business, located in Milwaukee, WI. This most recent Validation is for the PredictiMed AI Risk Burden Calculator. The output of this risk model also calculates potential medical claims cost, or Risk Burden, of the population. The USHC calculator uses valid estimates of the disease incidence and cost (Risk Burden) of 12 illnesses. These illnesses are the focus of USHC's risk reduction programs, whose goal is to improve health status and reduce health plan expenses.

USHC was honored to receive its first validation in 2015 when the Institute validated PredictiMedAI's "ability to identify and lower pre disease high risk level for 13 conditions, which may lead to 80 to 93% higher use of ER and hospital services". USHC has also been the recipient of the Institute's highest level Health Value Award for Care Navigation (Gold Level - 2019) and Population Health Management (Gold Level - 2020).

USHC provides services to employers, health plans, health systems, Third Party Administrators, Coalitions and Government institutions. With clients in all 50 states, the Company's on-going mission is the improvement of health outcomes, reduction of chronic disease incidence, as well as direct and indirect healthcare costs. US HealthCenter's PredictiMed new generation Predictive Modeling Analytics Engine and an early preventive and preemptive intervention was evaluated by the CI Validation Institute and validated as to its predictive accuracy and presymptomatic intervention and its ability to provide primary guarantee of positive outcomes to it's clients.

"Our mission is the prevention and management of disease using industry leading health management science technology and advocacy. The recognition by Validation Institute of all facets of our model certifies we are on par with our mission and the hard work our team has spent to bring personal predictive health to the market", said Gavin Quinnies, CEO and Co-Founder.

USHC has developed its proprietary predictive AI software platform integrating big data and cloud computing into a (SaaS) model to assist employers, consumers, health plans, providers and insurers in the identification and management of pre-disease, disease and end stage disease states and associated medical costs across the entire continuum of care. USHC's business intelligence solution utilizes integrated data to identify health risks, treatment gaps and inefficiencies and applies practical, clinically validated solutions to the medical management process in order to improve quality and lower costs.

Validation Institute's goal is to help organizations involved in population health - from Health Plans to Employers to Vendors - adhere to the highest standards of validity, allowing them to compete on the basis of integrity and performance rather than hyperbole. The Validation Institute will impartially challenge the status quo of typical population health outcomes measurement, with the objective of impacting how the industry establishes its credibility. Visit https://www.validationinstitute.com to learn more.

Contact:

US HealthCenter, Inc.
Gavin Quinnies
(262) 236-4056
janean@ushcinc.com
www.ushealthcenterinc.com

SOURCE: US HealthCenter



View source version on accesswire.com:
https://www.accesswire.com/708617/US-HealthCenters-PredictiMedTM-Receives-Another-Validation-from-Validation-Institute-for-its-Risk-Burden-Calculator

© 2022 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.